ArticleRheumatology (Oxford, England)2023
COVID-19 antiviral therapy for non-hospitalized immunosuppressed patients with rheumatic diseases is feasible with positive outcomes.
Chung M A Lin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.